Mitochondrial Disease
Resources
Medications
Insurance Assistance
Forzinity
Kygevvi
Get Involved
Research
About Us
Donate
Donate Now
Energy for Life
Family Impact Fund
Match Your Gift
Get Support
UMDF Co-signs Letter Encouraging Congress to “Act Swiftly” to Reauthorize the Rare Pediatric Disease PRV Program
Mito Advocacy
,
Press Room
Last Updated:
Sep 11, 2025 @ 12:12 pm
Search for:
Categories
About Mito
Conference
Research News
Position Statements
Corporate Partner
Fundraising
Mito Champion Spotlight
Donor Spotlight
Recent Posts
April 2026 Newsletter: 30 Years of Progress
Saol Therapeutics Provides Update from Type C Meeting with FDA regarding DCA
Ask the Mito Doc – March 2026
UMDF Co-Signs Letter to CMS Laying Out How Proposed ACA Changes Could Affect Existing Medical Nutrition Coverage
September 2025 Newsletter: World Mito Week, FDA News, Return of Ask The Mito Doc & Bench-to-Bedside
A Special World Mitochondrial Disease Week Message from UMDF President & CEO Kristen Clifford
Related Posts
April 2026 Newsletter: 30 Years of Progress
Read more
Saol Therapeutics Provides Update from Type C Meeting ...
Read more
UMDF Co-Signs Letter to CMS Laying Out How Proposed AC...
Read more
